SPC174

Glýseról fenýlbútýrat

  • Status:
    Veitt
  • Application date:
    20.12.2016
  • Application published:
    15.1.2017
  • Grant published:
    15.3.2018
  • Max expiry date:
    30.11.2030
  • Medicine name:
    Ravicti
  • Medicine for children:
    No

Timeline

Today
20.12.2016Application
15.1.2017Publication
15.3.2018Registration
30.11.2030Expires

Marketing license

  • IS authorization number:
    EU/1/15/1062/001-004
  • Date:
    16.12.2015
  • Foreign authorization number:
    EU/1/15/1062
  • Date:
    27.11.2015

Owner

  • Name:
    Immedica Pharma AB
  • Address:
    Norrtullsgatan 15, Stockholm SE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents